Researchers used 3D imaging and AI to map over 10 million oligodendrocytes in mouse brains, revealing regional myelin patterns relevant to neurological disease.
Key Details
- 1Johns Hopkins team mapped over 10 million oligodendrocytes in each mouse brain using 3D imaging, tissue clearing, and light-sheet microscopy.
- 2Machine learning was used to automatically identify and catalog cells, creating detailed maps of cell locations and gene expression.
- 3Maps showed regional differences—areas with more direct sensory input had three times more oligodendrocytes than others.
- 4Myelin formation and oligodendrocyte addition varied by brain region and over the lifespan, following a rigid developmental program.
- 5Damaged myelin was more vulnerable near amyloid plaques in a mouse Alzheimer's model and in certain brain regions after induced injury.
- 6Data and maps are freely available for researchers, aiming to accelerate further discoveries in brain disorders.
Why It Matters
This work combines AI and imaging to reveal new insights into myelin's role in brain function and vulnerability in neurological disease, offering high-resolution tools for studying conditions like MS and Alzheimer's. Freely accessible maps may propel new advances in neuroimaging and radiology research.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.